Inactive Instrument

Calendar PFIZER Euronext Paris

Equities

PFZ

US7170811035

End-of-day quote Euronext Paris
- - Intraday chart for PFIZER

Chart calendar PFIZER

c2fdf78dc7a9dbeddbb4976ca.-BlJIW7tjbFR6bmlb9Jn5YIp0pNZ3QdAYZQUOI-AetQ.nys5FAOytPMUvsDtNqgQ0exZm_IyinEoK6EsCcGxEe2RYxhIAp740x28iQ~62b8b64e91ba0a584fc4c06defa51372

Upcoming events on PFIZER

2024-07-30 06:45 Q2 2024 Earnings Release
2024-07-30 10:30 Q2 2024 Earnings Call
2024-10-28 Q3 2024 Earnings Release (Projected)
2025-02-03 Q4 2024 Earnings Release (Projected)
2025-05-05 Q1 2025 Earnings Release (Projected)
2025-08-04 Q2 2025 Earnings Release (Projected)

Past events on PFIZER

2024-06-10 11:20 Goldman Sachs Global Healthcare Conference
2024-06-03 14:45 American Society of Clinical Oncology Meeting - Abstract No: 3509
2024-06-03 10:00 American Society of Clinical Oncology Meeting - Abstract No: 5531
2024-06-03 10:00 American Society of Clinical Oncology Meeting - Abstract No: 7522
2024-06-03 10:00 American Society of Clinical Oncology Meeting - Abstract No: 7053
2024-06-03 09:00 American Society of Clinical Oncology Meeting - Abstract No: 4503
2024-06-03 09:00 American Society of Clinical Oncology Meeting - Abstract No: 4502
2024-06-02 10:00 American Society of Clinical Oncology Meeting - Abstract No: 4563
2024-06-02 10:00 American Society of Clinical Oncology Meeting - Abstract No: 4562
2024-06-02 10:00 American Society of Clinical Oncology Meeting - Abstract No: 5063
2024-06-02 10:00 American Society of Clinical Oncology Meeting - Abstract No: 5061
2024-06-02 10:00 American Society of Clinical Oncology Meeting - Abstract No: 5021
2024-06-02 10:00 American Society of Clinical Oncology Meeting - Abstract No: 1105
2024-06-02 10:00 American Society of Clinical Oncology Meeting - Abstract No: 1111
2024-06-01 17:30 American Society of Clinical Oncology Meeting - Abstract No: 8521
2024-06-01 16:00 American Society of Clinical Oncology Meeting - Abstract No: LBA7005
2024-06-01 16:00 American Society of Clinical Oncology Meeting - Abstract No: 5005
2024-06-01 16:00 American Society of Clinical Oncology Meeting - Abstract No: 3006
2024-06-01 10:00 American Society of Clinical Oncology Meeting - Abstract No: 3108
2024-05-31 15:45 American Society of Clinical Oncology Meeting - Abstract No: LBA8503

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
51 750
51 807
-0.11%
41 908
48 014
-12.72%
81 288
81 781
-0.6%
100 330
100 373
-0.04%
58 496
59 105
-1.03%

60 465

EBITDA
Million USD
Released
Forecast
Spread
21 097
22 824
-7.57%
17 801
21 398
-16.81%
25 426
29 444
-13.65%
42 336
44 597
-5.07%
15 590
11 249
38.59%

21 178

EBIT
Million USD
Released
Forecast
Spread
19 420
19 883
-2.33%
13 024
17 362
-24.99%
20 235
26 662
-24.11%
37 272
40 403
-7.75%
9 300
8 509
9.3%

16 881

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
17 682
22 426
-21.15%
7 497
13 166
-43.06%
24 311
19 569
24.23%
34 729
39 058
-11.08%
1 058
2 301
-54.02%

11 020

Net income
Million USD
Released
Forecast
Spread
16 273
19 053
-14.59%
9 616
16 066
-40.15%
21 979
22 567
-2.6%
31 372
33 053
-5.09%
2 119
3 040
-30.29%

7 279

EPS
USD
Released
Forecast
Spread
2,87
3,40
-15.62%
1,71
3,07
-44.24%
3,85
3,89
-0.9%
5,47
5,85
-6.45%
0,37
0,72
-48.44%

1,36

Announcement Date28/01/2002/02/2108/02/2231/01/2330/01/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD
Released
Forecast
Spread
25 661
24 734
3.75%
27 742
26 199
5.89%
22 638
21 091
7.33%
24 290
24 393
-0.42%
18 282
16 488
10.88%
12 734
13 398
-4.96%
13 232
13 429
-1.47%
14 249
14 396
-1.02%
14 879
13 923
6.87%

13 056


14 849


17 769


15 680


13 725

EBITDA
Million USD
Released
Forecast
Spread
11 135
13 710
-18.78%
13 583
12 434
9.25%
10 325
10 332
-0.06%
6 772
7 436
-8.92%
7 857
7 513
4.58%
4 925
4 000
23.13%
-1 244
-1 511
17.64%
1 340
-1 298
203.24%

4 403


3 759


4 681


4 537







EBIT
Million USD
Released
Forecast
Spread
9 948
9 738
2.16%
12 408
11 055
12.24%
9 142
9 092
0.55%
5 253
6 886
-23.71%
6 370
6 471
-1.56%
3 319
3 634
-8.68%
-1 625
-1 827
11.07%
-330
-1 404
76.5%
5 912
3 667
61.24%

3 406


3 790


4 094







Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
9 050








5 231
7 425
-29.55%






-3 352
2 207
-251.88%
-4 129
-3 139
-31.54%
3 421
2 992
14.34%

1 962


2 926


3 380







Net income
Million USD
Released
Forecast
Spread
7 864
8 418
-6.58%
9 906
9 799
1.09%
8 608
7 631
12.8%
4 995
5 667
-11.86%
5 543
4 495
23.31%
2 327


-2 382
-3 241
26.49%
-3 369
-2 371
-42.12%
3 115
1 951
59.69%

1 464


2 018


2 879







EPS
USD
Released
Forecast
Spread
1,37
1,60
-14.17%
1,73
1,64
5.73%
1,51
1,37
10.21%
0,87
0,69
25.48%
0,97
0,85
14.79%
0,41


-0,42
-0,51
16.83%
-0,60
-0,43
-41.06%
0,55
0,34
61.01%

0,24


0,36


0,50







Announcement Date03/05/2228/07/2201/11/2231/01/2302/05/2301/08/2331/10/2330/01/2401/05/24-----